Prevail Therapeutics, Inc.

Franz Hefti

Asa Abeliovich

Herve Rhinn

Laura Heckman

Hsuan-Ni Lin

Li Chin Wong

GENE THERAPIES FOR LYSOSOMAL DISORDERS

The disclosure relates to compositions and methods for treatment of diseases associated with aberrant lysosomal function, such as fronto-temporal dementia (FTD). The disclosure also provides expression constructs comprising a transgene encoding progranulin or a portion thereof. The disclosure provides methods of treating FTD by administering such expression constructs to a subject in need thereof.

Gene therapies for lysosomal disorders

The disclosure relates to compositions and methods for treatment of diseases associated with aberrant lysosomal function, such as Parkinson's disease and Gaucher disease. The disclosure provides expression constructs comprising a transgene encoding beta-glucocerebrosidase, an inhibitory RNA targeting alpha-Synuclein, or a combination of the foregoing. The disclosure further provides methods of treating Gaucher disease, Parkinson's disease or other synucleinopathies by administering such expression constructs to a subject in need thereof.

Growing community of inventors

New York, NY, United States of America

Franz Hefti